Literature DB >> 7901893

Functional alterations of the microflora in patients with ulcerative colitis.

P Benno1, C E Leijonmarck, U Monsén, A Uribe, T Midtvedt.   

Abstract

The aim of the study was to examine microflora-associated characteristics in patients with inactive ulcerative colitis, receiving sulphasalazine, in relation to the spread of the disease. The conversion of cholesterol to coprostanol, the production of urobilinogen, and the degradation of tryptic activity (FTA) and beta-aspartylglycine were measured in faecal samples from patients with proctitis or left-sided or total ulcerative colitis and in age- and sex-matched controls. No significant differences in the results were observed in patients with various degrees of extension of inflammatory bowel disease. However, the coprostanol ratio and the urobilinogen level were lower and the FTA was higher in patients with colitis than in the controls (p < 0.05). Beta-aspartylglycine was not found in any faecal sample. The results indicate that patients with ulcerative colitis taking sulphasalazine have a microflora with abnormal metabolic characteristics.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901893     DOI: 10.3109/00365529309104019

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  May bacterial or pancreatic proteases play a critical role in inflammatory bowel disease?

Authors:  Xiaofa Qin
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

2.  Kalopanaxsaponin A ameliorates experimental colitis in mice by inhibiting IRAK-1 activation in the NF-κB and MAPK pathways.

Authors:  Eun-Ha Joh; Dong-Hyun Kim
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

3.  Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis.

Authors:  Sahar K Hegazy; Mohamed M El-Bedewy
Journal:  World J Gastroenterol       Date:  2010-09-07       Impact factor: 5.742

4.  Lancemaside A ameliorates colitis by inhibiting NF-kappaB activation in TNBS-induced colitis mice.

Authors:  Eun-Ha Joh; In-Ah Lee; Sang-Jun Han; Sunju Chae; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2009-12-03       Impact factor: 2.571

5.  Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis.

Authors:  Jung-Hee Lee; Bomi Lee; Hye-Sung Lee; Eun-Ah Bae; Hoyong Lee; Young-Tae Ahn; Kwang-Sei Lim; Chul-Sung Huh; Dong-Hyun Kim
Journal:  Int J Colorectal Dis       Date:  2008-12-03       Impact factor: 2.571

6.  The degradation of glycosaminoglycans by intestinal microflora deteriorates colitis in mice.

Authors:  Hye-Sung Lee; Song-Yi Han; Kwon-Yeul Ryu; Dong-Hyun Kim
Journal:  Inflammation       Date:  2009-02       Impact factor: 4.092

7.  Dietary iron depletion at weaning imprints low microbiome diversity and this is not recovered with oral Nano Fe(III).

Authors:  Dora I A Pereira; Mohamad F Aslam; David M Frazer; Annemarie Schmidt; Gemma E Walton; Anne L McCartney; Glenn R Gibson; Greg J Anderson; Jonathan J Powell
Journal:  Microbiologyopen       Date:  2014-12-02       Impact factor: 3.139

8.  Faecal biomarkers can distinguish specific mammalian species in modern and past environments.

Authors:  Loïc Harrault; Karen Milek; Emilie Jardé; Laurent Jeanneau; Morgane Derrien; David G Anderson
Journal:  PLoS One       Date:  2019-02-07       Impact factor: 3.240

9.  Increase of faecal tryptic activity relates to changes in the intestinal microbiome: analysis of Crohn's disease with a multidisciplinary platform.

Authors:  Tore Midtvedt; Eugene Zabarovsky; Elisabeth Norin; Johan Bark; Rinat Gizatullin; Vladimir Kashuba; Olle Ljungqvist; Veronika Zabarovska; Roland Möllby; Ingemar Ernberg
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.